Quality Assurance

All human subjects research conducted under the University jurisdiction is subject to quality assurance (QA) monitoring. The quality improvement program is designed as a proactive, collaborative, and educational process that supports researchers in maintaining compliance and promotes high-quality research practices.Ìý

Goals

The goals of the QA program are to a) protect the rights and welfare of human participants in all University research; b) promote best practices in ethical research; c) identify, prevent, and mitigate risk to participants, investigators, and the institution; d) improve the quality and rigor of research through ongoing education and support; and e) foster a culture of transparency and accountability of participant data.Ìý

Program Objectives

To achieve these goals, the QA program will:Ìý

  • Verify adherence to IRB-approved protocols, consent materials, and study proceduresÌý
  • Confirm proper documentation and conduct of informed consent and assent/parental permissionÌý
  • Assess data security and confidentiality practices, including digital data management, storage, and de-identificationÌý
  • Evaluate recruitment, screening, and compensation proceduresÌý
  • Provide general guidance, targeted training, resources, and consultation to research teams throughout a project lifecycleÌý
  • Identify patterns or trends that may inform institutional improvements to policy or trainingÌý

Ìý

Routine Monitoring (not-for-cause)Ìý

The purpose of routine monitoring is to confirm compliance, to proactively identify and rectify potential issues, and to advise research teams. All human subjects research conducted at ÍøÆØ³Ô¹Ï is subject to routine monitoring, including human subject research determined to qualify for œexempt�-level review. Studies selected for routine monitoring are chosen without cause and randomly, but emphasis may be placed on studies that meet the following criteria:Ìý

  • Vulnerable populations (e.g., children, prisoners)Ìý
  • DeceptionÌý
  • Waivers (e.g., waivers of consent)
  • Greater than minimal riskÌý
  • Clinical trialsÌý
  • Federally fundedÌý
  • PIs with past findings of noncomplianceÌý

Selection for review does not imply noncompliance. Closed protocols or protocols in the data analysis-only phase will not be selected.

Directed Monitoring (for-cause) Ìý

Directed monitoring may occur in response to a specific concern or request, including when:Ìý

  • There are reports or evidence of noncompliance or of unanticipated problems involving risk to participants or othersÌý
  • In the judgment of the Vice Provost for Research (VPR), the ÍøÆØ³Ô¹Ï IRB (by majority vote), the IRB Chairperson, the Director of the Office for Research Protections (ORP), and/or institutional officialsÌý
  • The protection of human research subjects or the interests of the institution indicate the need for monitoringÌý

Back To Top